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Abstract
Introduction: The purpose of this study was to clarify whether type 2 diabetic patients with coronary disease are subject to similar benefits
in heart rate recovery (HRR) as non-diabetic counterpatrs after cardiac rehabilitation, assessing men and women subjects separately.
Material and methods: The data used for this analysis were from an eight-week, phase-II cardiac rehabilitation including 284 patients
with ischaemic heart disease who were managed at Tehran Heart Centre between July 2004 and January 2006. The heart rate parameters
were compared between diabetic and non-diabetic patients before and after cardiac rehabilitation. Diabetic and non-diabetic patients had
similar age and left ventricular ejection fraction.
Results: Among men, the non-diabetic patients achieved a greater improvement in peak heart rate and heart rate recovery (HRR). Addi-
tionally, lower resting heart rate was found in nondiabetic men after rehabilitation. In the women ≥ 50 years old, there was no significant
difference between diabetic and non-diabetic. The non-diabetic women < 50 years old showed significantly higher peak heart rate and
HRR compared with diabetic women.
Conclusions: These results indicate that the benefit of cardiac rehabilitation in HRR is significantly lower in type 2 diabetic men. Improve-
ment of HRR is not associated with diabetic status in women ≥ 50 years old. The response to cardiac rehabilitation in women may appear
to be influenced more by age at menopause rather than diabetes mellitus. (Pol J Endocrinol 2009; 60 (6): 430–436)
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Streszczenie
Wstęp: Celem badania było wyjaśnienie czy pacjenci z cukrzycą typu 2 i chorobą wieńcową odnoszą podobne korzyści z rehabilitacji
kardiologicznej dotyczące normalizacji częstości rytmu serca (HRR, heart rate recovery) jak osoby z chorobą wieńcową bez cukrzycy. Osob-
no oceniano mężczyzn i kobiety.
Materiał i metody: Dane wykorzystane w analizie pochodziły z 8-tygodniowego II stadium rehabilitacji kardiologicznej przeprowadzo-
nej u 284 pacjentów z chorobą niedokrwienną serca leczonych w Tehran Heart Center w okresie pomiędzy lipcem 2004 roku a styczniem
2006 roku. Porównywano parametry opisujące częstość rytmu serca u osób z cukrzycą i bez cukrzycy, przed i po rehabilitacji kardiologicz-
nej. Pacjenci z cukrzycą i bez cukrzycy charakteryzowali się podobnym wiekiem i zbliżoną frakcją wyrzutową lewej komory.
Wyniki: U mężczyzn bez cukrzycy uzyskano większą poprawę dotyczącą szczytowej częstości rytmu serca i normalizacji HRR. Dodatko-
wo po rehabilitacji, u mężczyzn bez cukrzycy stwierdzono mniejszą spoczynkową częstość rytmu serca. Nie zaobserwowano znamien-
nych różnic pomiędzy kobietami z cukrzycą i bez cukrzycy w wieku 50 lat i starszych. Kobiety bez cukrzycy poniżej 50. roku życia
charakteryzowały się istotnie większą szczytową częstością rytmu serca i HRR w porównaniu z kobietami z cukrzycą.
Wnioski: Uzyskane wyniki świadczą o tym, że korzyści z rehabilitacji kardiologicznej dotyczące HRR są istotnie gorsze u mężczyzn
z cukrzcą typu 2. Poprawa dotycząca HRR u kobiet w wieku 50 lat i starszych nie zależała od obecność cukrzycy. Wydaje się, że u kobiet
odpowiedź na rehabilitację kardiologiczną w większym stopniu zależy od wieku, w którym wystąpiła menopauza niż od obecności cukrzycy.
(Endokrynol Pol 2009; 60 (6): 430–436)
Słowa kluczowe: cukrzyca, rehabilitacja kardiologiczna, normalizacja częstości rytmu serca
431
Endokrynologia Polska/Polish Journal of Endocrinology 2009; 60 (6)
PR
A
C
E 
O
R
Y
G
IN
A
LN
E
Introduction
Heart rate recovery (HRR), as a powerful tool in the
investigation of autonomic modulation of the heart, was
demonstrated to be a powerful predictor of all-cause
mortality in healthy adults and in individuals with car-
diovascular disease [1–4].
Furthermore, HRR has been shown to be inversely
associated with insulin resistance, metabolic syndrome,
and type 2 diabetes mellitus [5–8].
It has been well established that cardiac rehabilitation
is associated with an improvement in HRR in patients with
heart failure and ischaemic heart disease [9–11]. It seems
that exercise training modifies the autonomic control
of cardiovascular function by favourably modulating
parasympathetic and sympathetic balance in patients
with heart disease. However, age, gender and certain
other factors may influence and interfere with the ef-
fects of exercise training on neurohumoral tone, as re-
flected by HRR in cardiac patients [12, 13].
To our knowledge, no previous study has specifi-
cally addressed the possible role of gender, and espe-
cially the menopausal status, regarding the relationship
between diabetes and HRR after cardiac rehabilitation.
The purpose of this investigation was to examine the
effects of gender and type 2 diabetes mellitus on HRR
response to an 8-week, hospital-based cardiac rehabili-
tation programme in patients with established ischa-
emic heart disease.
Material and methods
Our study population was drawn from a cohort of 284
patients with ischaemic heart disease (57.47 ± 11.10 years;
males: 72.2%) who had enrolled in and completed
a 24-session hospital-based cardiac rehabilitation betwe-
en July 2004 and January 2006. The investigation was
approved by the institutional review board governing
the participation of human subjects in research at the
Tehran University of Medical Sciences. In addition,
it conforms to the principles outlined in the Declara-
tion of Helsinki.
The inclusion criteria were selected patients with
coronary artery disease who had no previous coronary
artery bypass surgery, no neurologic impairment (stro-
ke, peripheral neuropathy, or traumatic brain injury),
no severe musculoskeletal disease (fracture, amputa-
tion), and no complications during hospitalization, such
as severe infection, shock, arrhythmia, or prolonged
ventilator dependence. Patients were excluded if they
displayed uncontrolled dysrhythmia during exercise
training, such as atrial flutter, fibrillation, or continu-
ous ventricular tachycardia, or if ischaemic changes
were observed on an electrocardiogram during tread-
mill exercise. Eligible subjects were patients who were
admitted to our tertiary teaching hospital following acu-
te myocardial infarction (AMI) or those who had un-
dergone coronary artery bypass grafting (CABG), per-
cutaneous coronary intervention (PCI), and percutane-
ous transvenous mitral commissurotomy (PTMC). Con-
firmation of eligibility was made by checking their
records for diagnosis on the day they were discharged.
Type 2 diabetic patients (n = 68) were studied in
comparison with non-diabetic controls (n = 216). The
demographic characteristics, atherosclerotic risk factor
profiles (including smoking, hyperlipidaemia, family hi-
story of CAD, hypertension, and diabetes mellitus), and
exercise treadmill parameters were extracted from the
Hospital Databank and documents recorded in the Car-
diac Rehabilitation Registry. Diabetes mellitus (symp-
toms of diabetes and plasma glucose concentration
≥ 200 mg/dl or fasting plasma glucose ≥ 126 mg/dl or
2-hp ≥ 200 mg/dl) was diagnosed based on: patients
self-report of use of hypoglycaemic medications, fasting
glucose measurement, and a recent patient’s medical
record. Information on other medications, including
b-blockers, calcium chanel blockers, angiotensin-conver-
ting enzyme (ACE) inhibitors, and anti-hyperlipidaemic
agents, were substantiated with use of other registries
(i.e., Angiography, CABG, and PTMC) and outpatient
clinics.
The complete cardiac rehabilitation program was
20 minutes of cardiovascular exercise on a treadmill for
8 weeks, with a total of 24 exercise sessions (3 per week).
There were approximately 20 minutes of stretching and
calisthenics for warm-up, and the session finished with
20 minutes of stretching and calisthenics for cool-down.
Total duration of each session was approximately
1 hour. The intensity of the aerobic exercise was patient
dependent. The training intensity was increased as tole-
rated by the patients. Heart rate, blood pressure, and exer-
cise intensity were monitored and supervised by a senior
cardiopulmonary physical therapist during the exercise
session. All patients received psychological and dietary
counselling. During the psychological sessions, the patients
were offered coping strategies in order to accept and live
with their cardiac incident. During the dietary counsel-
ling, the subjects received education sessions on healthy
nutrition and were included in a food program.
The main measurements were exercise treadmill pa-
rameters registered at the first and the last sessions of
the cardiac rehabilitation program. These parameters
included resting heart rate, peak heart rate achieved
during treadmill exercise, post-exercise heart rate, and
HRR. Heart rate recovery was defined as the decrease in
heart rate from the end of peak exercise to the first mi-
nute of the recovery and cool-down period (peak heart
rate subtracted by post-exercise heart rate).
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For the categorical variables, the statistical signifi-
cance of the difference between the groups was evalu-
ated at baseline and after cardiac rehabilitation using
chi-square or Fisher’s exact tests. The continuous varia-
bles were expressed as the mean ± standard deviation
(SD) or median (25%, 75% interquartile range), being
parametrical or non-parametrical, respectively. Age and
left ventricular ejection fraction (LVEF) were analyzed
by Student’s t-test. The values of the first session (i.e.
resting heart rate1, peak heart rate1, end-exercise heart
rate1, and HRR1) and the end session (i.e. resting heart
rate2, peak heart rate2, post-exercise heart rate2, and
HRR2) were analyzed and compared between and wi-
thin the two groups using Mann-Whitney U and Wil-
coxon Sign tests, respectively. Analyses were performed
using the Scientific Package for Social Science version
15 (SPSS Inc., Chicago, IL, USA) and SAS (version 9.1;
Copyright 2002–2003 by SAS Institute Inc., Cary, NC,
USA). For all comparisons, a p value less than 0.05 was
required, to be statistically significance.
Results
Demographic and clinical data for the sample are no-
ted in Table I. No significant differences were obse-
rved between diabetic and non-diabetic patients con-
cerning age, LVEF, tobacco smoking, family history of
CAD, cause of recent admission (AMI, CABG, PCI, and
other procedures), or cardiovascular medications (ACE
inhibitors, b-blockers, Ca-channel blockers, aspirin,
and hypolipidaemic agents). Moreover, the medical
treatments in women < 50 or ≥ 50 years old were
similar in the diabetic and non-diabetic groups
(Table II). The diabetic subjects were more likely to
have hypertension and hyperlipidaemia. In other
words, systolic blood pressures in the first and the end
sessions were significantly higher in the diabetic pa-
tients compared with the controls. Prevalence of fe-
male gender was significantly higher in the diabetic
group in comparison with nondiabetics (45.6%
v. 22.2%; p < 0.001).
For the men and women, the statistics of resting
heart rate, peak heart rate, post-exercise heart rate, HRR,
and DHRR are listed separately in Tables III and IV. For
the men, there was no significant difference between
the diabetic and non-diabetic groups in resting hart rate,
peak heart rate, and HRR at the first session. After eight
weeks of rehabilitation, the groups of diabetic and non-
diabetic male patients showed significant increases in
peak heart rate and HRR, but significant decreases in
resting heart rate. The diabetic male subjects, compa-
red with those without diabetes, showed significantly
lower values for peak hart rate (122 [112.5, 131] v. 128
[120, 139.5]; p = 0.019), HRR (24 [19, 32] v. 30 [21, 36];
p = 0.029), and DHRR (18 [8.5, 23] v. 22 [15, 29]; p = 0.030)
after cardiac rehabilitation.
Table I. Clinical and demographic characteristics of patients
Tabela I. Kliniczna i demograficzna charakterystyka chorych
Diabetic group Non-diabetic group p value
(n = 68) (n = 216)
 Age (years) 58.91 ± 9.39 57.01 ± 11.05 0.203
Women, no.% 31 (45.6%) 48 (22.2%) < 0.001
Hypertension, no.% 39 (57.4%)  80 (37%) 0.003
Current smoker, no.% 11 (16.2%) 57 (26.5%) 0.082
Hyperlipidaemia, no.% 47 (69.1%) 110 (50.9%) 0.009
Family history, no.% 29 (42.6%) 89 (41.2%) 0.833
LVEF (%) 51.95 ± 9.91 51.84 ± 10.32 0.940
Aspirin, no.% 62 (91.2%) 197 (91.2%) 0.994
b-blockers, no.% 56 (82.4%) 172 (79.6%)  0.623
Calcium channel blockers, no.% 15 (22.10%) 49 (22.7%) 0.914
ACEi, no.% 24 (35.3%) 69 (31.9%) 0.608
Anti-hyperlipidaemic agents, no.% 41 (60.3%) 113 (52.3%) 0.249
Diagnosis, no.%
CABG 49 (71.1%) 129 (59.7%)
PCI 11 (16.2%) 33 (15.3%) 0.066
Rother 8 (11.8%) 54 (25.0%)
LVEF — left ventricular ejection fraction; ACE — angiotensin-converting enzyme inhibitors; CABG — coronary artery bypass grafting; PCI — percutaneous
coronary intervention
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Primary analysis in women showed that HRR was
significantly lower in diabetic women during the first
session compared with non-diabetics, but it was similar
at the end session (20 [11, 32] v. 18 [10, 25]; p = 0.279).
Actually, both groups had a similar pattern of DHRR.
Neither resting heart rate nor peak heart rate were si-
gnificantly different between diabetic and non-diabe-
tic women, whether at the first or the end session. After
completing the rehabilitation programme, both female
groups showed significant increases in peak heart rate
and HRR, but significant decreases in resting hart rate.
Although the average age was not significantly diffe-
rent between diabetic and non-diabetic female patients
(59.13 ± 9.11 v. 58.23±10.25; p = 0.692), we performed
further analyses to assess the possible role of age with
respect to the menopausal effect on heart rate. By using
the knowledge of age at menopause among Iranian
women [14], a cutoff of < 50 years was considered for
the onset of natural menopause in this population. In
the women ≥ 50 years, only the first session HRR was
significantly lower in diabetic patients in comparison
to non-diabetics (5 [3, 10.] v. 8 [4, 14]; p = 0.022). Howe-
ver, for women under 50 years of age, the parameters
of the first session were found to be similar between
diabetic and non-diabetic patients, while after eight
weeks of rehabilitation, peak heart rate, HRR, and
DHRR were significantly lower in diabetic patients com-
pared with non-diabetic patients (Table IV).
Discussion
The concept of the body’s physiological response and
the therapeutic benefits of physical aerobic training have
rapidly increased over recent decades. Exercise training
may reduce mortality and protect against adverse car-
diovascular events in both healthy individuals and type
2 diabetic patients. Several biological mechanisms have
been proposed to this effect, but the relative importan-
ce of these exercise-related mechanisms is still unknown.
Increased parasympathetic tone is thought to be a pro-
tective mechanism of cardiac rehabilitation [15] and can
be related to heart rate variability during exercise tra-
ining. Vagal reactivation mediates the rate at which the
heart rate recovers to normal levels after exercise [16–
18]. It is known that persistently high heart rates can be
a manifestation of cardiac parasympathetic dysfunction
in those with type 2 diabetes and that persistently high
heart rates at rest significantly correlate with increased
mortality in the general population [19, 20].
Table II. Medical treatment in women < 50 and ≥ 50 years
old, comparing diabetic and non-diabetic groups
Tabela II. Farmakoterapia u kobiet w wieku < 50 i ≥ 50 lat,
porównanie między grupami chorych na cukrzycę i osób bez
cukrzycy
Age < 50 years
Diabetic Non-diabetic p value
group group
(n = 5) (n = 9)
Aspirin, no.% 4 (80%) 7 (77.8%) 0.924
b-blockers, no.% 4 (80%) 7 (77.8%) 0.924
Calcium channel 1 (20%) 2 (22.2%) 0.923
blockers, no.%
ACEi, no.% 1 (20%) 2 (22.2%) 0.923
Anti-hyperlipidaemic 2 (40%) 4 (44.4%) 0.873
agents, no.%
Age ≥ 50 years
Diabetic Non-diabetic p value
group group
(n = 26) (n = 39)
Aspirin, no.% 24 (92.3%) 35 (89.7%) 0.723
b-blockers, no.% 22 (84.6%) 32 (82%) 0.784
Calcium channel 6 (23.1%) 8 (20.5%) 0.803
blockers, no.%
ACEi, no.% 9 (34.6%) 13 (33.3%) 0.914
Anti-hyperlipidaemic 16 (61.5%) 21 (53.8%) 0.539
agents, no.%
ACE — Angiotensin-converting enzyme inhibitors
Table III. Values of treadmill exercise parameters at the first
and the end sessions of cardiac rehabilitation in men
Tabela III. Parametry opisujące test wysiłkowy na bieżni
wykonany na początku i na końcu sesji rehabilitacji
kardiologicznej u mężczyzn
Diabetic Non-diabetic p value
group  group
(n = 37) (n = 168)
Resting heart rate1 83 79 0.346
[beats/min] (70, 89) (68, 89)
Peak heart rate1 98 95 0.635
[beats/min] (85.5, 109) (86, 108)
Post-exercise heart rate1 90 88 0.629
[beats/min] (78.5, 97.5) (78, 98)
Resting heart rate2 77 78 0.852
[beats/min] (69.5, 83.5) (68, 85)
Peak heart rate2 122 128 0.019
[beats/min] (112.5, 131) (120, 139.5)
Post- exercise heart rate2 95 100 0.471
[beats/min] (88.5, 107.5)  (90, 106)
HRR1 [beats/min] 6 7 0.985
(5, 10)  (5, 10)
HRR2 [beats/min] 24 30 0.029
(19, 32)  (21, 36)
DHRR [beats/min] 18 22 0.030
(8.5, 23) (15, 29)
HRR — heart rate recovery
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One of the main findings of this study, based on the
pre-and post-exercise training condition, is that
a 24-session cardiac rehabilitation programme for
patients with ischaemic heart disease leads to signifi-
cant improvements in cardiovascular autonomic func-
tion of HRR, comparing pre- and post-exercise training
condition. It could serve as a potential adjunct therapy
in the management of CAD with or without type 2 dia-
betes. However, 8.4% of the present population did not
show any improvement in HRR. From this small sub-
set, 62.5% were women ≥ 50 years old. It is in agre-
ement with the previous study by Kligfield et al. [9],
who found a decrease in HRR in about 9% of the sub-
jects after 12 weeks of rehabilitation. They studied only
a group of patients > 65 years old, which was dispro-
portionately female. In our sample, there was a strong
correlation between gender and diabetes mellitus.
Therefore, we analyzed separately the role of gen-
der and type 2 diabetes mellitus on HRR after cardiac
rehabilitation. Previous studies have demonstrated that
vagal modulation of heart rate during exercise is inde-
pendent of age [21]. However, Hao et al. [22] showed
the proportional increase in HRR after training in older
patients was greater than that found in younger pa-
tients, suggesting that older patients derive much be-
nefit from exercise training. In our study, non-diabetic
and diabetic patients were matched for age in both gen-
ders, and the possible age-related effect on HRR was
omitted.
Our data showed, as was expected, that a lower
improvement of HRR is associated with type 2 diabetic
status among male patients, according to previous stu-
dies. The lower heart rate response to exercise in diabe-
tics could possibly result from inappropriate secretion
of catecholamines in the heart [23–27]. It was also sug-
gested that the sensitivity of the sinus node to norepi-
nephrine is deteriorated in diabetic patients [25]. In pri-
mary analysis (data not shown), we found no signifi-
cant different between diabetic and non-diabetic wo-
men pertaining to improvement of HRR. Although both
groups had a similar average age, we tested another
hypothesis considering ≥ 50 years old as the age of me-
nopause for Iranian women [14]. In women under the
age of natural menopause, eight-week exercise training
resulted in a higher peak heart rate, HRR, and DHRR
in non-diabetic patients compared with diabetics. Ho-
wever, diabetic status had no significant effect on peak
heart rate and HRR in women older than the set age at
menopause. Kuo et al. [28] demonstrated that women
younger than 50 years old have dominant vagal and
subordinate sympathetic activity compared with age-
matched men. However, gender-related differences
were not detected in older subjects. Given the correla-
tion between female gender and type 2 diabetes melli-
tus, as well as the distinct effect of hormonal changes
on autonomic balance in menopause transition, it is
surprising that diabetes and menopause status share an
Table IV. Values of treadmill exercise parameters at the first
and the end sessions of cardiac rehabilitation in women
Tabela IV. Parametry opisujące test wysiłkowy na bieżni
wykonany na początku i na końcu sesji rehabilitacji
kardiologicznej u kobiet
Age < 50 years
Diabetic Non-diabetic p value
group  group
(n = 5) (n = 9)
Resting heart rate1 95 88 0.797
[beats/min]  (79.5, 95.5)  (79, 95)
Peak heart rate1 111 100 0.240
[beats/min] (100.5, 116.5)  (95, 111)
Post-exercise heart 99 92 0.438
rate1 [beats/min]  (91, 108.5) (86, 107)
Resting heart rate2 81 77 0.699
[beats/min]  (69, 89.5) (72, 89)
Peak heart rate2 111 130 0.012
[beats/min] (107, 125)  (124, 138)
Post- exercise heart 100 105 0.606
rate2 [beats/min] (92.5, 103.5)  (85, 108)
HRR1 [beats/min] 8 8 1.000
(3, 16) (4.5, 10.5)
HRR2 [beats/min] 17 31 0.019
(8, 25) (24, 39.5)
DHRR [beats/min] 4 27 0.029
(–1.5, 17.5)  (17.5, 30)
Age ≥ 50 years
Diabetic Non-diabetic p value
group  group
(n = 26) (n = 39)
Resting heart rate1 87 86 0.241
[beats/min]  (79, 96) (72, 92)
Peak heart rate1 105 98 0.979
[beats/min]  (91, 112) (94, 12)
Post-exercise heart 96 91 0.417
rate1 [beats/min] (84, 102)  (85, 99)
Resting heart rate2 77 74 0.753
[beats/min]  (66, 83) (65, 84)
Peak heart rate2 110 114 0.529
[beats/min]  (97, 128)  (101, 123)
Post- exercise heart 89 90 0.902
rate2 [beats/min] (81, 100)  (82, 98)
HRR1 [beats/min] 5 8 0.022
(3, 10)  (5, 14)
HRR2 [beats/min] 19 17 0.913
(10, 27)  (10, 29)
DHRR [beats/min] 10 7.5 0.627
(4, 19) (–6, 24)
HRR — heart rate recovery
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effect on heart rate. To explain this, we propose a hy-
pothesis which states that decreased hormonal stores
cause remarkable autonomic neural dysfunction, which
exceeds the effects of diabetes mellitus in patients with
CAD. Consistent with these results, it was shown that
there are some links between hormonal changes, insu-
lin resistance, and higher levels of cardiovascular risk
factors in women with polycystic ovary syndrome. The-
se associations appear to be particularly strong in wo-
men who are younger [29]. In other words, one would
predict that pre-menopausal women would be the most
likely to benefit from a tight control of hyperglycaemia,
not to develop a non-responsive status of autonomic
balance. However, most human studies [12, 15, 30–32]
have not demonstrated a significant difference in spon-
taneous autonomic activity between postmenopausal
women with oestrogen replacement therapy and those
without it. Until now, the role of oestrogen in the auto-
nomic control of gender-related differences or meno-
pausal autonomic changes has remained ambiguous.
One limitation of this study is its retrospective de-
sign with inherent bias. Although heart rate, blood pres-
sure, and exercise intensity were monitored and super-
vised by a senior cardiopulmonary physical therapist
for all patients, baseline and follow-up exercise stress
tests were not performed and the data was recorded
during treadmill exercise training. Nevertheless, these
findings seem to be an indicator of parameters of exer-
cise stress test. Ideally, however, the study needs to be
confirmed in a prospectively conducted randomized
trial with entry and exit exercise stress testing.
Conclusions
Exercise training within a structured programme of car-
diac rehabilitation was correlated with a significant in-
crease in peak heart rate, HRR, regardless of the clinical
and demographic characteristics of patients with coro-
nary artery disease. However, the male patients with
type 2 diabetes mellitus were less likely to achieve the
improvements for these parameters after cardiac reha-
bilitation. In women younger than menopausal age,
there was a similar pattern with respect to the effects of
diabetes. Despite of the lack of enough evidence con-
cerning the association between the study outcomes and
autonomic balance, heart rate might be more influen-
ced by postmenopausal status rather than diabetes
mellitus after cardiac rehabilitation in women.
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